Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
B Cells versus T Cells in the Tumor Microenvironment of Malignant Lymphomas. Are the Lymphocytes Playing the Roles of Muhammad Ali versus George Foreman in Zaire 1974?
Desmirean M, Rauch S, Jurj A, Pasca S, Iluta S, Teodorescu P, Berce C, Zimta AA, Turcas C, Tigu AB, Moldovan C, Paris I, Steinheber J, Richlitzki C, Constantinescu C, Sigurjonsson OE, Dima D, Petrushev B, Tomuleasa C. Desmirean M, et al. Among authors: berce c. J Clin Med. 2020 Oct 24;9(11):3412. doi: 10.3390/jcm9113412. J Clin Med. 2020. PMID: 33114418 Free PMC article. Review.
Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis.
Teodorescu P, Pasca S, Jurj A, Gafencu G, Joelsson JP, Selicean S, Moldovan C, Munteanu R, Onaciu A, Tigu AB, Buse M, Zimta AA, Stiufiuc R, Petrushev B, Desmirean M, Dima D, Vlad C, Bergthorsson JT, Berce C, Ciurea S, Ghiaur G, Tomuleasa C. Teodorescu P, et al. Among authors: berce c. J Cell Mol Med. 2020 Oct;24(19):11100-11110. doi: 10.1111/jcmm.15526. Epub 2020 Sep 5. J Cell Mol Med. 2020. PMID: 32889753 Free PMC article.
Protein dysregulation in graft versus host disease.
Qian L, Dima D, Berce C, Liu Y, Rus I, Raduly LZ, Liu Y, Petrushev B, Berindan-Neagoe I, Irimie A, Tanase A, Jurj A, Shen J, Tomuleasa C. Qian L, et al. Among authors: berce c. Oncotarget. 2017 Dec 15;9(1):1483-1491. doi: 10.18632/oncotarget.23276. eCollection 2018 Jan 2. Oncotarget. 2017. PMID: 29416707 Free PMC article. Review.
Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia.
Tomuleasa C, Fuji S, Berce C, Onaciu A, Chira S, Petrushev B, Micu WT, Moisoiu V, Osan C, Constantinescu C, Pasca S, Jurj A, Pop L, Berindan-Neagoe I, Dima D, Kitano S. Tomuleasa C, et al. Among authors: berce c. Front Immunol. 2018 Feb 19;9:239. doi: 10.3389/fimmu.2018.00239. eCollection 2018. Front Immunol. 2018. PMID: 29515572 Free PMC article. Review.
Genetically enhanced T lymphocytes and the intensive care unit.
Tat T, Li H, Constantinescu CS, Onaciu A, Chira S, Osan C, Pasca S, Petrushev B, Moisoiu V, Micu WT, Berce C, Tranca S, Dima D, Berindan-Neagoe I, Shen J, Tomuleasa C, Qian L. Tat T, et al. Among authors: berce c. Oncotarget. 2018 Mar 27;9(23):16557-16572. doi: 10.18632/oncotarget.24637. eCollection 2018 Mar 27. Oncotarget. 2018. PMID: 29662667 Free PMC article. Review.
Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome.
Jurj A, Pop L, Petrushev B, Pasca S, Dima D, Frinc I, Deak D, Desmirean M, Trifa A, Fetica B, Gafencu G, Selicean S, Moisoiu V, Micu WT, Berce C, Sacu A, Moldovan A, Colita A, Bumbea H, Tanase A, Dascalescu A, Zdrenghea M, Stiufiuc R, Leopold N, Tetean R, Burzo E, Tomuleasa C, Berindan-Neagoe I. Jurj A, et al. Among authors: berce c. Crit Rev Clin Lab Sci. 2018 Nov;55(7):501-515. doi: 10.1080/10408363.2018.1499707. Epub 2018 Sep 21. Crit Rev Clin Lab Sci. 2018. PMID: 30238808 Review.
MicroRNA-155-5p Plays a Critical Role in Transient Leukemia of Down Syndrome by Targeting Tumor Necrosis Factor Receptor Superfamily Members.
Sas V, Pasca S, Jurj A, Pop L, Muramatsu H, Ono H, Dima D, Teodorescu P, Iluta S, Turcas C, Onaciu A, Munteanu R, Zimta AA, Blag C, Popa G, von Gamm EDA, Arghirescu S, Serban M, Man S, Marian M, Petrushev B, Berce C, Colita A, Zdrenghea M, Kojima S, Gulei D, Takahashi Y, Tomuleasa C. Sas V, et al. Among authors: berce c. Cell Physiol Biochem. 2020 Oct 3;54(5):994-1012. doi: 10.33594/000000283. Cell Physiol Biochem. 2020. PMID: 33006449 Free article.
Correction: Genetically enhanced T lymphocytes and the intensive care unit.
Tat T, Li H, Constantinescu CS, Onaciu A, Chira S, Osan C, Pasca S, Petrushev B, Moisoiu V, Micu WT, Berce C, Tranca S, Dima D, Berindan-Neagoe I, Shen J, Tomuleasa C, Qian L. Tat T, et al. Among authors: berce c. Oncotarget. 2018 Aug 10;9(62):32097. doi: 10.18632/oncotarget.25983. eCollection 2018 Aug 10. Oncotarget. 2018. PMID: 30174800 Free PMC article.
KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma.
Pasca S, Tomuleasa C, Teodorescu P, Ghiaur G, Dima D, Moisoiu V, Berce C, Stefan C, Ciechanover A, Einsele H. Pasca S, et al. Among authors: berce c. Front Oncol. 2019 Oct 24;9:1137. doi: 10.3389/fonc.2019.01137. eCollection 2019. Front Oncol. 2019. PMID: 31709194 Free PMC article.
50 results